g207
Biologicalexperimental
China National Highway 207 (G207) runs from Ulanhot, Inner Mongolia to Hai'an, Guangdong. It is 3,738 km (2,323 mi) in length and runs south from Xilinhot through Inner Mongolia, Hebei, Shanxi, Henan, Hubei, Guangxi, and ends in Guangdong. — Wikipedia
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2001 (NCT00028158)
Timeline
Indications
Studied for
- Astrocytoma · Phase 2
- Brain Diseases · Phase 1
- Brain Neoplasms · Phase 1
- Central Nervous System Diseases · Phase 1
- Central Nervous System Neoplasms · Phase 1
- Cerebellar Diseases · Phase 1
- Cerebellar Neoplasms · Phase 1
- Glioblastoma · Phase 2
- Glioma · Phase 2
- Herpes Simplex · Phase 1
- Medulloblastoma · Phase 1
- Neoplasm Metastasis · Phase 1
- Neoplasms · Phase 2
- Neoplasms by Histologic Type · Phase 1
- Neoplasms by Site · Phase 1
- Neoplasms, Germ Cell and Embryonal · Phase 1
- Neoplasms, Glandular and Epithelial · Phase 1
- Neoplasms, Nerve Tissue · Phase 1
- Neoplasms, Neuroepithelial · Phase 1
- Nervous System Diseases · Phase 1
- Nervous System Neoplasms · Phase 1
- Neuroectodermal Tumors · Phase 1
- Neuroectodermal Tumors, Primitive · Phase 1
- Supratentorial Neoplasms · Phase 1
- Viruses · Phase 1
Mechanism of action
- Oncolytic virusOTHER
Oncolytic virus other
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaChina National Highway 207 ↗
Also known as
- g207
- g207
- g207
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04482933 | Phase 2 | Oct 1, 2020 | Treovir, LLC, University of Alabama, Birmingham |
| NCT03911388 | Phase 1 | Jul 1, 2019 | University of Alabama, Birmingham |
| NCT02457845 | Phase 1 | May 1, 2016 | University of Alabama, Birmingham |
| NCT00157703 | Phase 1 | May 1, 2005 | MediGene, National Cancer Institute (NCI) |
| NCT00028158 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2001 | MediGene |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Alabama, Birmingham | Academic/Hospital | 3 | 3 | 2 | 2016 |
| MediGene | For profit | 2 | 2 | 2 | 2001 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2005 |
| Treovir, LLC | For profit | 1 | 0 | 1 | 2020 |
4 organizations
Page 1 / 1